Clover Health Sees 27% Growth in Medicare Members

An update from Clover Health Investments ( (CLOV) ) is now available.

Clover Health announced a significant 27% growth in its Medicare Advantage membership following a successful Annual Election Period, reaching over 100,000 members, with 95% enrolled in its 4-Star PPO plan. This growth, driven by robust plan benefits and a high Star rating, positions the company for continued success and profitability in 2025, supported by strategic investments in technology and care management improvements. The strong membership increase and anticipated payment increases in 2026 reflect Clover’s strong market positioning and commitment to enhancing healthcare quality.

More about Clover Health Investments

Clover Health Investments (Nasdaq: CLOV) is a physician enablement technology company focused on providing access to high-quality healthcare for Medicare beneficiaries, especially seniors who have historically lacked access. The company leverages its software platform, Clover Assistant, to aggregate patient data and support clinical decision-making. Clover Health offers Medicare Advantage PPO and HMO plans in several states and extends its technology benefits to a wider audience through its subsidiary, Counterpart Health.

YTD Price Performance: 16.29%

Average Trading Volume: 6,152,864

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $1.82B

For an in-depth examination of CLOV stock, go to TipRanks’ Stock Analysis page.